Love Pharma Updates Terms For Acquisition Of Psychedelic Researcher Microdoz Therapy
LOVE Pharma Co. (CSE:LUV) (FSE:G1Q0) updated details on the proposed Microdoz Therapy acquisition, whereby Microdoz has engaged exclusively with researchers at Johns Hopkins University, to conduct a landmark study into the potential of psilocybin assisted treatment of cannabis use disorder.
